Laura Gault
Direttore Tecnico/Scientifico/R&S presso SAGE THERAPEUTICS, INC.
Patrimonio netto: 2 465 $ in data 30/06/2024
Profilo
Laura Gault is currently the Chief Medical Officer at SAGE Therapeutics, Inc. Prior to her current position, she worked as the Vice President at Alexion Pharmaceuticals, Inc. from 2019 to 2022 and as the Vice President-Neurology Clinic Development at Vertex Pharmaceuticals, Inc. from 2017 to 2019.
Gault received her undergraduate degree from the University of Pittsburgh and her doctorate from Case Western Reserve University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SAGE THERAPEUTICS, INC.
0.00% | 31/03/2024 | 227 ( 0.00% ) | 2 465 $ | 30/06/2024 |
Posizioni attive di Laura Gault
| Società | Posizione | Inizio |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 31/10/2022 |
Precedenti posizioni note di Laura Gault
| Società | Posizione | Fine |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/11/2022 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/03/2019 |
Formazione di Laura Gault
| Case Western Reserve University | Doctorate Degree |
| University of Pittsburgh | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SAGE THERAPEUTICS, INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| Aziende private | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Laura Gault
